- Company Overview for AMPLYX PHARMA UK LTD (10057683)
- Filing history for AMPLYX PHARMA UK LTD (10057683)
- People for AMPLYX PHARMA UK LTD (10057683)
- More for AMPLYX PHARMA UK LTD (10057683)
Persons with significant control: 1 person with significant control / 0 statements
Pfizer, Inc.
- Correspondence address
- 235 East 42nd Street, New York, United States, NY 10017
- Notified on
- 27 April 2021
- Governing law
- Legal form
- Corporation
- Nature of control
- Ownership of voting rights - 75% or more
- Right to appoint or remove directors
Statement Withdrawn
- The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company
- Notified on
- 10 March 2017
- Withdrawn on
- 27 April 2021